The problem with pharma companies that are heavily counting on one drug to work and get approved is that if said drug doesn’t work as well as hoped and get approved then you can take some major losses... nothing has reward without risk... but what i saw this one does look fairly promising...

This company's balance sheet is also very strong... it has almost a 3x

That being said they have been issueing quite a large amount of stock for quite some time...

Definatly not the wost company i have looked at but if this drug fails for soem reason it could spell some LARGE losses... but like I also said no risk it without its reward